Shellback Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,958
| Closed | -$3.47M | – | 128 |
|
|
2024
Q1 | $3.47M | Buy |
+50,958
| New | +$3.47M | 0.23% | 100 |
|
|
2021
Q4 | – | Sell |
-40,000
| Closed | -$4.48M | – | 109 |
|
|
2021
Q3 | $4.48M | Buy |
40,000
+17,239
| +76% | +$1.93M | 0.26% | 80 |
|
|
2021
Q2 | $3.69M | Buy |
+22,761
| New | +$3.69M | 0.2% | 101 |
|